• (000) 123 458 789
  • office@worldpatientsalliance.org
Home Events Patient Advocacy: Driving Change in Healthcare

Patient Advocacy: Driving Change in Healthcare

Webinar Report: Patient Advocacy in Asia Pacific Region

The WPA Asia Pacific Region organized a webinar titled " Patient Advocacy: Driving Change in Healthcare " on April 23, 2025. The event brought together patient advocates, healthcare leaders, and policy influencers from across the world especially, Asia Pacific region. The goal was to explore the fundamentals of patient advocacy, share successful case studies, and encourage stronger regional collaborations.

The webinar was accessible through AI-powered simultaneous translation into over 50 languages, ensuring broad inclusivity.

Welcome and Opening Remarks:
The webinar opened with a warm welcome by Andrew Spiegel, Chair of the World Patients Alliance. He emphasized the importance of patient voices in shaping healthcare policies and systems.
Following his remarks, Andrew introduced the moderator, Hussain Jafri, CEO of WPA. Hussain outlined the agenda, objectives, and introduced the distinguished speakers.

Key Objectives of the Webinar:
• Strengthen patient advocacy efforts across the Asia Pacific region.
• Share successful advocacy models and practices.
• Encourage the use of evidence-based approaches in patient advocacy.
• Foster collaboration between patient groups, healthcare providers, and policymakers.

Key Presentations:

Introduction and Fundamentals of Advocacy

Tamás Bereczky provided an insightful presentation on the definitions and distinctions between advocacy and activism. He emphasized that both are essential tools for creating social and political change. He discussed the critical role of evidence-based advocacy, urging patient organizations to base their campaigns on data and research rather than anecdotal experiences.

Tamás highlighted challenges patient organizations face, such as limited knowledge and resources for conducting research. He presented models of patient involvement in research, policy, and healthcare design, showing how patient-driven data can influence real change.

Case Studies on Patient Advocacy from WPA Asia Pacific Region

Edmund Lau

Edmund Lau shared his journey of advocacy through the Psoriasis Association of Singapore. He introduced two models for driving policy change: the TAQA Model (Timely, Affordable, Quality, Access) and the 4Es Model (Education, Exposure, Exploitation, Exploration).

He presented the advocacy campaign by Psoriasis Association of Singapore to emphasize the urgent need to recognize psoriatic disease as a systemic illness, not just a skin condition. Through sustained advocacy around World Psoriasis Day, his team influenced healthcare reforms focused on holistic care, early intervention, and mental health support.

Mecciya Majrashi

Mecciya Majrashi presented the story behind Motaafi Cancer Care Association, Saudi Arabia. She outlined how advocacy can be structured through an “Advocacy Plan," including environmental scans, policy analysis, power mapping, goal setting, and dissemination strategies.

Mecciya stressed the importance of training advocates, building strong media connections, and continually evaluating advocacy efforts. Her experiences, both as a cancer survivor and advocate, demonstrated the value of perseverance, strategic planning, and collaboration with civil society networks.

JS Arora

JS Arora shared the inspiring journey of thalassemia advocacy in India. His work led to the inclusion of Thalassemia under “Benchmark Disabilities" in India's Rights of Persons with Disabilities (RPWD) Act 2016.

He described years of lobbying, protests, and public campaigns that finally secured legal rights for thalassemia patients, including free healthcare, education benefits, and social security schemes. Despite progress, he pointed out ongoing challenges like the lack of job reservations for thalassemia patients in government employment, showing that advocacy is an ongoing effort.

Panel Discussion and Q&A:

The panel discussion, moderated by Hussain Jafri, brought together all speakers to share reflections on the future of patient advocacy.

Key themes included:

• Evidence-based Advocacy: All speakers agreed on the need for professionalizing advocacy through data collection and research.
• Community Engagement: Engaging patients directly in research design and healthcare decisions was highlighted as a priority.
• Policy Influence: Advocates stressed working collaboratively with policymakers and other health care stake holder to embed patient voices in healthcare reforms.
• Challenges Ahead: Speakers shared concerns about sustaining advocacy movements, especially with limited resources in some regions.
Audience questions sparked discussion on building resilient patient organizations and navigating cultural barriers in advocacy.

Key Takeaways
1. Invest in Capacity Building: Train patient advocates in evidence based data collection, policy engagement, and communication skills.
2. Leverage Data: Base advocacy campaigns on strong evidence to increase credibility and impact.
3. Foster Cross-Sector Collaboration: Work with healthcare providers, academia, and civil society to amplify patient voices.
4. Sustain Momentum: Develop long-term strategies to keep advocacy efforts alive beyond short-term projects.

The webinar highlighted the growing strength of patient advocacy in the Asia Pacific region. Through shared experiences, practical models, and collective learning, advocates can build a more patient-centred healthcare environment. The WPA remains committed to supporting patient voices and advancing safe, accessible, and quality healthcare for all.

Agenda

Speakers

Tamás Bereczky, PhD
I currently work as a study coordinator at Deutsche Aidshilfe e.V. (German AIDS Alliance), the umbrella association for HIV organisations in Germany. I am responsible for coordinating the West-European leg of the EMIS-2023/24 study, a large-scale sociological research that looks at the sexual and mental health of men who have sex with men, and trans people. I am also the project coordinator of CORE – Community Response to End Inequalities, a unique project supported by the European Union that provides capacity building and support for community-based and community-led service providers in the fields of HIV, viral hepatitis, tuberculosis, and STIs. Since 2014, I have also contributed to the courses and contents of the European Patients’ Academy for Therapeutic Innovation (EUPATI). I have been working as a trainer, lecturer, course coordinator, meeting facilitator and content developer for EUPATI, various organisations, and universities. I focus on developing training courses and processes for patient engagement both for patient and advocacy organisations, and the pharmaceutical industry. As a researcher, I have been engaged in exploring and understating matters related to patient involvement in research and development, HTA, and other fields. Living with HIV since 2003, I served as a member of the board of directors of the European AIDS Treatment Group (EATG) for almost 4 years and also served as the co-chair of the European Commission’s Civil Society Forum on HIV/AIDS between 2013 and 2015; and have been involved in numerous EU and global projects. I have been a member of The BMJ Patient Panel since 2017. I was a member of the European Community Advisory Board (ECAB) on HIV from 2004 to 2024 and am also a member of the German Community Advisory Board (D-CAB). I sat on the Scientific Committee of the European AIDS Clinical Society in 2015 and held the opening keynote speech at the EACS Conference in that same year. I attended numerous HIV-related conferences (CROI, EACS, IAS, Glasgow) as a patient representative, session convener, session chair, and speaker. I have been publishing regularly in scientific journals as part of my engagement in different projects, and as an independent researcher and author. Besides, I have also produced a wealth of information materials (videos, articles, and websites) in my native Hungarian for people who live with HIV. You can read my works in English, German, and Hungarian here: https://tatk.academia.edu/TamasBereczky
J.S. Arora
J.S. Arora is the General Secretary of National Thalassemia Welfare Society & Federation of Indian Thalassemia. He is a Patients for Patients Safety (PFPS) Champion since 2007 and is also serving as a member of the Advisory Group of WHO’s Patients for Patients Safety Program since 2014. Dr. Arora is the founder member of the Indian Alliance of Patient Groups as well the founding trustee of the Genomics And Public Health Foundation. He has previously served as Coordinator of Thalassemia Cell, DHS, Delhi as well as member of Hospital Advisory Committee, DDU Hospital, Delhi and the State VAT Advisory Committee, Delhi. He is also a member of State Blood Transfusion Council. He is the author of Florilegium of Thalassemia and co-author of several publications including a chapter in the postgraduate textbook Pediatrics and Care & Control of Thalassemia: In the New Millennium” 2000.
Edmund Lau
Edmund is an esteemed Associate Lecturer with extensive experience teaching at universities in the US, UK, Australia, Singapore, and other international higher learning institutions. Edmund’s academic background is robust, having recently been offered a place at the prestigious University College London (UCL) Doctorate in Business Administration (DBA) Health programme. He is also in the process of completing his LL.M. Masters in International Law from the University of Lincoln in the UK and the Master of Health Economics from the University of Newcastle in Australia. A dedicated advocate for patients with chronic conditions, Edmund has successfully managed his psoriasis with biologic treatment, significantly improving his work capacity and quality of life. His journey has earned him the title of ’10x Productive Chronic Patient’, inspiring others facing similar health challenges. Edmund is committed to advancing the application of Artificial Intelligence in healthcare, recognising its potential to revolutionise patient care and improve health outcomes globally. His insights and experiences make him a valuable contributor to the 2nd World Patients Conference.
Mecciya Majrashi
Mecciya Majrashi completed her MBA in Total Quality Management in 2012 From University of Leicester, Leicester, United Kingdom and holds a rich 20-year experience in healthcare sectors. She has been appointed as the President of Saudi Patient Experience Club since January 2022. She is also the part of a team working with the Patient Advocacy Council since 2019 representing a group of individuals committed to engaging with one another, sharing ideas and expanding the engagement of Patient Advocate Leaders in The Beryl Institute community from different entities around the world. Mecciya is also a Board Member at Motaafi (Cancer Survivor foundation) since March 2018 where she helps in developing strategies and extends support to the Executive Board Members for achieving the goals, objectives, and better outcomes. She also helps in preparing for policy Design and Advocacy interlinkages between the Civil Society Engagement Group for Non-profits organization (C20) and G20. Mecciya believes that she owes her life to Kingdom of Saudi Arabia that ensured excellent treatment to all cancer patients and provided care that enabled Mecciya to live and work to her full potential so far.

Date

Apr 23 2025
Expired!

Time

8:00 am - 10:00 am
Category

Leave A Reply

Your email address will not be published. Required fields are marked *